1. Home
  2. PRSU vs IOVA Comparison

PRSU vs IOVA Comparison

Compare PRSU & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

N/A

Current Price

$35.00

Market Cap

946.6M

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$3.69

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRSU
IOVA
Founded
1926
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
946.6M
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
PRSU
IOVA
Price
$35.00
$3.69
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
$31.67
$10.08
AVG Volume (30 Days)
182.9K
11.1M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.24
$57.99
Revenue Next Year
$6.25
$52.63
P/E Ratio
$3.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.90
$1.64
52 Week High
$39.93
$4.57

Technical Indicators

Market Signals
Indicator
PRSU
IOVA
Relative Strength Index (RSI) 48.84 71.60
Support Level $34.61 $1.94
Resistance Level $37.75 $3.73
Average True Range (ATR) 1.24 0.23
MACD -0.14 0.13
Stochastic Oscillator 58.98 63.21

Price Performance

Historical Comparison
PRSU
IOVA

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: